Literature DB >> 18097020

CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity.

Hannah Richards1, M Paula Longhi, Kate Wright, Awen Gallimore, Ann Ager.   

Abstract

The down-regulation of CD62L that accompanies T lymphocyte activation is thought to redirect cells away from lymph nodes to sites of infection. In this study, CD62L was maintained on Ag-activated T cells and their distribution, and ability to clear pathogen from peripheral sites determined. CD62L was down-regulated on Ag-specific CD8 T cells in lungs of C57BL/6 mice but maintained in CD62L transgenic mice at day 8 after influenza infection. However, the numbers of influenza-specific CD8 T cells recruited were similar in CD62L transgenic and C57BL/6 mice. Memory CD8 T cell numbers in the lungs and noninvolved organs 100 days after primary infection were similar in CD62L transgenic and C57BL/6 mice, despite differing CD62L expression. Transgenic mice expressing wild-type CD62L cleared a recombinant vaccinia virus expressing an influenza-derived CD8 T cell epitope as efficiently as C57BL/6 mice. However, transgenic mice expressing a protease resistant mutant of CD62L showed significantly delayed viral clearance, despite normal CTL generation and the presence of CD107a and IFN-gamma expressing influenza-specific CD8 T cells. These results demonstrate that CD62L down-regulation is not required for CD8 memory cells to home to sites of infection. However, their ability to clear virus is significantly compromised if CD62L shedding is abrogated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097020     DOI: 10.4049/jimmunol.180.1.198

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Authors:  Jason P Twohig; Morgan Marsden; Simone M Cuff; John R Ferdinand; Awen M Gallimore; William V Perks; Aymen Al-Shamkhani; Ian R Humphreys; Eddie C Y Wang
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

Review 2.  Migration, maintenance and recall of memory T cells in peripheral tissues.

Authors:  David L Woodland; Jacob E Kohlmeier
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

Review 3.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

4.  Intestinal CD4 Depletion in HIV / SIV Infection.

Authors:  Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

5.  HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Authors:  Lia Vassena; Erica Giuliani; Herwig Koppensteiner; Sebastian Bolduan; Michael Schindler; Margherita Doria
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 6.  Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration.

Authors:  David Finlay; Doreen Cantrell
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

7.  Circulating L-selectin expressing-T cell subsets correlate with the severity of Foxp3 deficiency autoimmune disease.

Authors:  Yuying Liu; Thomas K Hoang; Ting Wang; Baokun He; Dat Q Tran; Jain Zhou; Nina Tatevian; J Marc Rhoads
Journal:  Int J Clin Exp Pathol       Date:  2016-02-15

8.  Impaired memory CD8 T cell responses against an immunodominant retroviral cryptic epitope.

Authors:  Melanie R Rutkowski; Cynthia A Stevens; William R Green
Journal:  Virology       Date:  2011-02-04       Impact factor: 3.616

Review 9.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Concurrent generation of effector and central memory CD8 T cells during vaccinia virus infection.

Authors:  Amale Laouar; Monika Manocha; Viraga Haridas; N Manjunath
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.